IGF-1 LR3 stands for insulin-like growth factor-1, an abbreviation of its full long-form chemical name – Insulin-like Growth Factor 1 Receptor Subtype 3. It’s a peptide growth hormone which is naturally produced in the body, and it’s been studied extensively for its ability to stimulate cell growth, recovery, and overall health. But what makes IGF-1 LR3 truly unique is the fact that it can be used for research objectives that aim to push the frontiers of human potential.

The IGF-1 LR3 peptide is being clinically studied for its role in anti-aging, hypertrophy, and lipolysis (fat burning). Although usage of the peptide for research in humans is currently not approved, the promise of daring experiments someday leading to longer life expectancies and improved athletic performance isn’t too far away. But before exploring the potential of IGF-1 LR3, let’s look closer into its history, natural origins, and current evidence of efficacy for research purposes.

In 1985, the naturally produced receptor for IGF-1 LR3 was discovered by scientists in the United States. It was identified as a hormone receptor that’s highly active in the liver, skeletal muscles, and fat cells – all three of which are of great interest for bodybuilding and anti-aging researchers alike. Soon after its discovery, it sparked great interest in pharmaceutical research and development, as it was seen as a promising biomarker for research in physiology and pathology due to its demonstrated properties for regenerative effects in the body.

The fact that the IGF-1 LR3 peptide naturally exists in the body has been a powerful advantage for researchers who want to simulate the behavior of an endogenous hormone – that is, a hormone naturally produced in the body. This has paved the way for its usage in anti-aging, performance and health research deemed safe for use, in the event of explicit precautions being taken.

The unique design of IGF-1 LR3 enables unparalleled advantages in the research arena. The peptide is a bonded compound, composed of 83 amino acids that were previously found in the endogenous growth factor IGF-1. As a short peptide hormone it also has increased stability, making it ideal for prolonged usage in clinical or research conditions. This has allowed researchers to use IGF-1 LR3 for a wide array of applications, from muscle building to therapeutic cardio and neuro-degenerative disorders.

Perhaps the most acclaimed feature of IGF-1 LR3 is its ability to stimulate sustained muscle growth. Studies have shown that in animals IGF-1 LR3 can lead to increased muscle mass due to an “anabolic window” - consistently exceeding half a month of remarkable violations. Furthermore, studies have demonstrated that IGF-1 LR3 can increase endurance, boost recovery times and reduce inflammation – all properties making it an ideal candidate for use in endurance-oriented research, with weight training as a side benefit.

Most importantly, IGF-1 LR3 is responsible for the stimulation of human growth hormone production. This may lead to improved fat utilization and an increased metabolic rate, as well as increased glycemic control, which is important for combating diabetes. The exact mechanism of action for IGF-1 LR3’s ubiquitous usage in research has yet to be fully explored, however, due to its strong reputation as a research stimulant fueled by its natural formula, its usage is supported by constant efforts to understand its mechanism more accurately.

Explicit Supps ensures that your research compound endeavors are compliant with the highest purity standards through rigorous testing conducted by independent laboratories. Our unique selection of premium SARMs, peptides, nootropics and supplements sets the standard for quality, backed up by uncompromising commitment and customer-centric approach. Join us in advancing scientific discovery and innovation.

Topics:

IGF1 LR3,

bodybuilding,

peptides